Outbreak of Yellow Fever in Brazil: Clinical considerations, diagnosis and its implications
11th Annual Congress on Immunology
July 26-28, 2018 | Moscow, Russia
Patricia Fabrini, Marco Fabrini Araujo and Lorran Fabrini Araujo
Santhe Clinic, Brazil
Posters & Accepted Abstracts : Timely Top Clin Immunol
Abstract:
Yellow fever (YF), a mosquito-borne viral hemorrhagic fever, is one of the most lethal viral diseases.YF first registers in Brazil dated in 1685. The disease was erradicated in 1942. Virus transmission is highest during the rainy season (January-March) in Brazil , when the number of insects that transmict the disease is high.It is characterized by a rapid evolution and hepatitis, renal failure, hemorrhage, shock, and death; the mortality rate is 20%-50%.The diagnosis is based on viral Antigens detection or when antibodies titles are higher than 4X. To prevent the disease, prophylactic measures and vaccination must be highlighted.The vacination can be iniciated by nine months of age. Last studies have shown that the immunization in adults can provide permanent immunization.To control the epidemics, precaution against exposure to vector mosquitoes,as a continuous ritual and the proper use of 17D vaccine to prevent infection in travelers must be highlighted.Including the verification of vaccination card in the airports, while checking passports must restrict YF in the world .In Brazil, vacination and continued prophylatic measures can erradicated, in the a near future, this disease again.
Biography:
Patrícia Fabrini helds a infusional center in Belo Horizonte , Minas Gerais, Brazil. She also works as a dermatologist in Santa Casa , a great hospital in the city.She is nowadays responsible for the infusion of many of the patients diagnosed with immunomediated diseases, like Psoriaisis, Arthritis, Crohn’s disease and Ankyloosing Spondyhlitis where patients with psoriasis and arthritis receive immunobiological treatment.
E-mail: saudesanthe@hotmail.com
PDF HTML